Pancreatic Cancer Research

ResearcherVirginia Commonwealth UniversityActive in the last 2 years

Emma Charlotte Fields

Matched on ORCID iD 0000-0002-2871-078X; OpenAlex author ID A5032602245. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 6

  1. Unresectable Pancreatic Adenocarcinoma: Evidence-Based Medicine or a Gut Feeling? First author DOI 10.1016/j.ijrobp.2024.11.091↗
  2. Clinical outcomes in borderline and locally advanced pancreatic cancer with the addition of low-dose-rate brachytherapy to standard of care therapy. Last author DOI 10.1016/j.brachy.2024.01.008↗
  3. CivaSheet intraoperative radiation therapy for pancreatic cancer. Last author DOI 10.1016/j.brachy.2021.10.007↗
  4. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic R… Co-author DOI 10.3390/jcm11092584↗
  5. First report on the feasibility of a permanently implantable uni-directional planar low dose rate brachytherapy sheet for patients with resectable or borderlin… Last author DOI 10.1016/j.brachy.2020.08.010↗
  6. Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation. Last author DOI 10.21037/jgo.2016.11.09↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John G. Roubil · 1 shared paper, 2025 · strength 0.54
  2. Ross J. Taylor · 2 shared papers, 2022–2024 · strength 0.51
  3. Brian J. Kaplan · 3 shared papers, 2016–2022 · strength 0.45
  4. Joshua B. Dault · 1 shared paper, 2021 · strength 0.17
  5. Robert Hawranko · 1 shared paper, 2022 · strength 0.16
  6. William Y. Song · 1 shared paper, 2022 · strength 0.16
  7. Justin D. Anderson · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.